SinuSonic Announces Presentation of Double-Blind, Sham-Controlled Trial Data Showing Regular Use of the Device Improved Nasal Congestion
May 26, 2022 12:31 ET | Healthy Humming, LLC
COLUMBIA, S.C., May 26, 2022 (GLOBE NEWSWIRE) -- SinuSonic, a brand of Healthy Humming, LLC, is pleased to announce the presentation of the results from their study on "Double-blind, sham-controlled...
Twin Cities Birth Center, Formerly Health Foundations, Unveils New Name, Patient Portal
April 12, 2022 07:00 ET | Twin Cities Birth Center
MINNEAPOLIS, April 12, 2022 (GLOBE NEWSWIRE) -- Twin Cities Birth Center, formerly Health Foundations, announces the unveiling of its new name, website, and patient portal. "As our team and business...
Ananda Professional is Opening Enrollment to Participate in an IRB-Approved Phase IV Clinical Trial Investigating How CBD May Benefit Women's Health and Wellness
March 07, 2022 13:00 ET | Ananda Professional
GEORGETOWN, Ky., March 07, 2022 (GLOBE NEWSWIRE) -- Ananda Professional has committed $40 million to advance the clinical evidence of hemp extract through clinical research.  As part of this...
Social enterprise, Lucky Iron Fish, completes Series A Funding with a new investment from Danone Communities to better help address iron deficiency
October 25, 2021 07:50 ET | Lucky Iron Fish
Toronto, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Toronto, ON (Oct 22, 2021) — Lucky Iron Fish Enterprise (LIFe) is pleased to announce the completion of a $1 Million Series A funding, led by Danone...
Obseva Logo highresolution.jpg
ObsEva to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021 01:00 ET | ObsEva SA
GENEVA, Switzerland September 7, 2021 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today...
femasys logo 2.jpg
Femasys Inc. Announces First Patient Treated in Pivotal Trial for FemaSeed
July 20, 2021 08:31 ET | Femasys Inc.
First in Class Insemination Treatment for Infertility LOCAL Pivotal Trial to Enroll Up to 792 Patients Across 20 U.S. Centers ATLANTA, July 20, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:...
Lucky Iron Fish receives $250k in funding to help address iron deficiency anemia in Benin.
June 30, 2021 12:32 ET | Lucky Iron Fish
Toronto, June 30, 2021 (GLOBE NEWSWIRE) -- Lucky Iron Fish Enterprise (LIFe) is an impact-driven company that is on a mission to tackle iron deficiency globally using their innovative solutions...
Agile_Logo-color on white.jpg
Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Monday, March 1, 2021
February 19, 2021 08:35 ET | Agile Therapeutics, Inc.
Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will...
Aerobic Vaginitis (AV) Testing Now Available At BioReference Laboratories
May 17, 2019 08:30 ET | Bio-Reference Laboratories
Elmwood Park, NJ, May 17, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health company, along with its specialty women’s health division, GenPath, today announces the launch of...
BioReference Laboratories to Present at ACOG 2019, Demonstrating Commitment to the Research of Hereditary Conditions
May 02, 2019 17:05 ET | Bio-Reference Laboratories
Elmwood Park, NJ, May 02, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company, along with its women’s health division GenPath, today announced the presentation of new...